BIO-Europe Vienna: Successful Partnering for CANTREAT – and a Clear Signal for Our Mission

What a fantastic event! BIO-Europe in Vienna impressively demonstrated the power of a well-connected life-science ecosystem. From excellent organization and short distances to strong international presence, Vienna was simply ideal as a trade fair location. Even more important: the quality and depth of the conversations were consistently high. CANTREAT leveraged precisely this environment to sharpen and actively advance our vision and mission: to bring innovative therapies into clinical development faster, more reliably, and with a patient-centered approach.

Over three intensive days, we were able to initiate numerous valuable partnerships and speak with potential investors about our pipeline and next milestones. Our highlights included productive 1:1 meetings with leading international biotech and pharma players, concrete follow-ups with future development partners, and in-depth discussions on financing, scaling, and study planning. For CANTREAT, these conversations mean more than networking: they are building blocks of a robust development pathway—from early proof-of-concept through translational transfer to clinical trials. Throughout, we consistently pursue three principles: scientific excellence, regulatory rigor, and pragmatic feasibility. We believe that meaningful impact for patients is created where strong data meets clear clinical needs.

A big thank-you goes to the BIO-Europe organizers and to everyone who took the time to engage with us. We look forward to the next steps and to turning these new contacts into long-term collaborations—with a clear focus on patient benefit.